[21C2-21C2];[21E2-21E2];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
21C2;21E2
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Inferred to overlap with: Df(2L)BSC456.
Presence of P+PBac{XP5.WH5}BSC107 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(2L)BSC107 predicted from the P{XP}d00080 and PBac{WH}CG2813f05607 Release 3 genome coordinates are 21C5;21D1.